Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China flag China · Delayed Price · Currency is CNY
63.30
-0.20 (-0.31%)
Apr 14, 2026, 3:00 PM CST

Xiamen Amoytop Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25,83834,15729,84721,29615,83711,911
Market Cap Growth
-19.57%14.44%40.15%34.47%32.96%-14.13%
Enterprise Value
24,99933,47329,27220,67015,36011,446
Last Close Price
63.3083.6872.7651.5438.1328.57
PE Ratio
25.1233.1236.0638.3455.1865.73
Forward PE
19.9728.1228.1228.1228.1228.12
PS Ratio
6.999.2410.6010.1410.3710.52
PB Ratio
7.499.9011.6911.3511.2510.26
P/TBV Ratio
8.5411.2912.5312.6412.3211.74
P/FCF Ratio
54.6072.18166.4895.23109.98271.61
P/OCF Ratio
35.4346.8369.3141.5943.6150.73
EV/Sales Ratio
6.769.0610.399.8410.0610.11
EV/EBITDA Ratio
18.7125.2229.2928.9838.0943.97
EV/EBIT Ratio
20.6027.5831.4631.3242.6651.64
EV/FCF Ratio
52.8370.73163.2892.42106.67260.99
Debt / Equity Ratio
0.050.050.000.000.010.02
Debt / EBITDA Ratio
0.130.130.010.010.020.10
Debt / FCF Ratio
0.370.370.050.040.070.57
Net Debt / Equity Ratio
-0.24-0.24-0.26-0.35-0.40-0.39
Net Debt / EBITDA Ratio
-0.63-0.63-0.65-0.93-1.39-1.75
Net Debt / FCF Ratio
-1.77-1.77-3.64-2.96-3.90-10.41
Asset Turnover
1.001.001.041.020.960.87
Inventory Turnover
0.770.770.820.891.391.18
Quick Ratio
3.233.233.552.803.044.01
Current Ratio
3.863.864.343.323.574.71
Return on Equity (ROE)
34.36%34.36%37.37%33.83%22.35%16.77%
Return on Assets (ROA)
20.43%20.43%21.51%19.99%14.09%10.59%
Return on Invested Capital (ROIC)
43.16%47.22%53.10%55.56%37.47%29.64%
Return on Capital Employed (ROCE)
33.10%33.10%35.40%33.80%24.00%17.80%
Earnings Yield
3.99%3.02%2.77%2.61%1.81%1.52%
FCF Yield
1.83%1.39%0.60%1.05%0.91%0.37%
Dividend Yield
0.98%0.74%0.85%0.80%0.56%0.35%
Payout Ratio
24.52%24.52%20.15%15.60%14.17%11.41%
Buyback Yield / Dilution
-0.38%-0.38%-0.56%-0.29%-0.39%-0.18%
Total Shareholder Return
0.60%0.36%0.30%0.50%0.17%0.18%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.